Cost Effectiveness of Ramipril in Patients with Non-Diabetic Nephropathy and Hypertension: Economic Evaluation of Ramipril Efficacy In Nephropathy (REIN) Study for Germany from the Perspective of Statutory Health Insurance
Year of publication: |
2001
|
---|---|
Authors: | Schadlich, Peter K. ; Brecht, Josef Georg ; Brunetti, Massimo ; Pagano, Eva ; Rangoonwala, Badrudin ; Huppertz, Eduard |
Published in: |
PharmacoEconomics. - Springer Healthcare | Adis, ISSN 1170-7690. - Vol. 19.2001, 5, p. 497-512
|
Publisher: |
Springer Healthcare | Adis |
Subject: | ACE inhibitors | Cost effectiveness | Hypertension | Kidney disorders | Pharmacoeconomics | Ramipril |
Extent: | application/pdf text/html |
---|---|
Type of publication: | Article |
Classification: | C - Mathematical and Quantitative Methods ; D - Microeconomics ; I - Health, Education, and Welfare ; Z - Other Special Topics ; I1 - Health ; I19 - Health. Other ; I18 - Government Policy; Regulation; Public Health ; I11 - Analysis of Health Care Markets |
Source: |
-
Cote, Isabelle, (2000)
-
Pharmacoeconomics of Hypertension Management: The Place of Combination Therapy
Ambrosioni, Ettore, (2001)
-
Measuring and Managing Health Outcomes and Quality of Care in End-Stage Renal Disease
Kinchen, Kraig S., (2001)
- More ...
-
Cost Effectiveness of Ramipril in Patients with Non-Diabetic Nephropathy and Hypertension
Schädlich, Peter, (2001)
-
Schadlich, Peter K., (2004)
-
Schadlich, Peter K., (1998)
- More ...